Skip to main content
SpringerLink
Log in

Annual Meeting der American Society of Clinical Oncology (ASCO) 2021

Neues in der zielgerichteten Therapie und Immuntherapie bei Lungenkrebs

  • Aktuell
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. ChA d. Klinik für Innere Medizin IV, Klinikum Chemnitz gGmbH\nKlinik für Innere Medizin IV, Bürgerstraße 2, 9116, Chemnitz, Germany

    Stefan Hammerschmidt

Authors
  1. Stefan Hammerschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Hammerschmidt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hammerschmidt, S. Neues in der zielgerichteten Therapie und Immuntherapie bei Lungenkrebs. Pneumo News 13, 51–52 (2021). https://doi.org/10.1007/s15033-021-2745-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-021-2745-5

Search

Navigation